Sarcoma
(Jan 2000)
Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
Thomas Brodowicz,
Eva Schwameis,
Joachim Widder,
Gabriele Amann,
Christoph Wiltschke,
Martin Dominkus,
Reinhard Windhager,
Peter Ritschl,
Richard Pötter,
Rainer Kotz,
Christoph C. Zielinski
Affiliations
Thomas Brodowicz
Clinical Division of Oncology, Vienna, Austria
Eva Schwameis
Department of Orthopedic Surgery, Vienna, Austria
Joachim Widder
Department of Radiotherapy and Radiobiology, Vienna, Austria
Gabriele Amann
Department of Clinical Pathology, University Hospital, Vienna, Austria
Christoph Wiltschke
Clinical Division of Oncology, Vienna, Austria
Martin Dominkus
Department of Orthopedic Surgery, Vienna, Austria
Reinhard Windhager
Department of Orthopedic Surgery, Vienna, Austria
Peter Ritschl
Department of Orthopedic Surgery, Orthopedic Hospital Gersthof, Vienna, Austria
Richard Pötter
Department of Radiotherapy and Radiobiology, Vienna, Austria
Rainer Kotz
Department of Orthopedic Surgery, Vienna, Austria
Christoph C. Zielinski
Clinical Division of Oncology, Vienna, Austria
DOI
https://doi.org/10.1155/2000/126837
Journal volume & issue
Vol. 4,
no. 4
Abstract
Read online
Purpose. The present prospective randomized adjuvant trial was carried out to compare the toxicity, feasibility and efficacy of augmented chemotherapy added to hyperfractionated accelerated radiotherapy after wide or marginal resection of grade 2 and grade 3 soft tissue sarcoma (STS).
WeChat QR code
Close
